Back

Hikma Pharmaceuticals shares rise 1.2% after naming next CFO

Verifying
  • Hikma Pharmaceuticals named Rebecca Hall as its next chief financial officer.
  • Shares rose 1.2% after Hall’s appointment was announced.
  • Areb Kurdi will remain interim CFO until Hall starts next year.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Hikma Pharmaceuticals shares rise 1.2% after naming next CFO - CoinPost Terminal